World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
17540
World Ranking
4184
National Ranking
1908

Overview

Michelle A. Lifton is affiliated with the Beth Israel Deaconess Medical Center in the United States. Their research primarily focuses on medicine and immunology and microbiology, with significant contributions to infectious diseases, immunology, and molecular biology. The scientist's work also touches on oncology and epidemiology as subfields of study.

The main research topics covered by Lifton include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, immune cell function and interaction, vaccines and immunoinformatics approaches, polyomavirus and related diseases, long-term effects of COVID-19, and immunotherapy and immune responses.

Michelle A. Lifton has published papers in several prominent scientific venues, with frequent publications in bioRxiv (Cold Spring Harbor Laboratory), Cell, Nature, the Journal of Virology, and The Journal of Infectious Diseases.

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques, 2020, Science
  • Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron, 2022, Nature
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature
  • CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques, 2022, Science Immunology
  • Vaccine protection against the SARS-CoV-2 Omicron variant in macaques, 2022, Cell

Frequent co-authors in Lifton's research include Dan H. Barouch, Jinyan Liu, Katherine McMahan, Jingyou Yu, and Catherine Jacob-Dolan. These collaborations have contributed to the depth and breadth of work on vaccine responses and immune protection mechanisms related to SARS-CoV-2.

Best Publications

  • Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes

    Jörn E. Schmitz;Marcelo J. Kuroda;Sampa Santra;Vito G. Sasseville

  • Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

    John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro

  • Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination

    Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda

  • Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu

  • SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

    Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan

  • Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

    Dan H. Barouch;Jennifer Kunstman;Marcelo J. Kuroda;Jörn E. Schmitz

  • Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

    Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink

  • Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

    Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal

  • Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein

    Shawn M. Sumida;Diana M. Truitt;Angelique A. C. Lemckert;Ronald Vogels

  • Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.

    Marcelo J. Kuroda;Jörn E. Schmitz;William A. Charini;Christine E. Nickerson

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.

    Galit Alter;Galit Alter;Jingyou Yu;Jinyan Liu;Abishek Chandrashekar

  • Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

    Dan H. Barouch;Abie Craiu;Marcelo J. Kuroda;Jörn E. Schmitz

  • Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.

    Dan H. Barouch;Sampa Santra;Marcelo J. Kuroda;Jörn E. Schmitz

  • Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys

    Dan H. Barouch;Jennifer Kunstman;Jennifer Glowczwskie;Kevin J. Kunstman

  • Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

    Shawn M. Sumida;Diana M. Truitt;Michael G. Kishko;Janelle C. Arthur

  • Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.

    Dan H. Barouch;Sampa Santra;Klara Tenner-Racz;Paul Racz

  • Simian Immunodeficiency Virus (SIV) gag DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection

    Michael A. Egan;William A. Charini;Marcelo J. Kuroda;Jörn E. Schmitz

  • Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge.

    Aruna Seth;Ilnour Ourmanov;Jorn E. Schmitz;Marcelo J. Kuroda

  • Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman Primates

    Sampa Santra;Michael S. Seaman;Ling Xu;Dan H. Barouch

  • Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

    Angelique A. C. Lemckert;Shawn M. Sumida;Lennart Holterman;Ronald Vogels

Frequent Co-Authors

Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Jörn E. Schmitz
Jörn E. Schmitz Harvard Medical School
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Sampa Santra
Sampa Santra Beth Israel Deaconess Medical Center
David C. Montefiori
David C. Montefiori Duke University
John W. Shiver
John W. Shiver United States Military Academy
Keith A. Reimann
Keith A. Reimann Harvard Medical School
Klara Tenner-Racz
Klara Tenner-Racz Bernhard Nocht Institute for Tropical Medicine
Paul Racz
Paul Racz Bernhard Nocht Institute for Tropical Medicine
Jaap Goudsmit
Jaap Goudsmit Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. One popular path is becoming a Nurse Practitioner, where understanding the immune system is essential. Many students seek the easiest online nurse practitioner programs to balance study with work and personal commitments.

Specializing further, a Psychiatric-Mental Health Nurse Practitioner (PMHNP) role is in high demand. Programs that offer robust clinical experience can make a big difference. Check out online pmhnp programs with clinical placement to ensure strong hands-on training.

Cost is a major consideration for students, so exploring the cheapest pmhnp programs can help you find budget-friendly options without sacrificing quality.

Advanced practice nurses often pursue a Doctor of Nursing Practice (DNP) degree. Understanding how much do dnps make is crucial for evaluating the return on investment and planning your career path effectively.

Best Scientists Citing Michelle A. Lifton

Trending Scientists

Recently Published Articles